Project Details
Description
WHEREAS, NRG Oncology seeks to improve the lives of cancer patients by conducting practice-changing multi-institutional clinical and translational research with emphases on gender-specific malignancies including gynecologic, breast and prostate cancers and on localized or locally advanced cancers of all types;
WHEREAS, NRG Oncology anticipates to receive award(s) from the National Institutes of Health (“NIH”) and the National Cancer Institute (“NCI”) to conduct oncology clinical trials;
WHEREAS, the Parties desire for Institution to participate in the conduct of the clinical trials;
Status | Finished |
---|---|
Effective start/end date | 3/1/14 → 7/31/19 |
Funding
- NRG Oncology Foundation, Inc. (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)
- National Cancer Institute (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.